Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cauda

Showing results (111-120 of 187) with videos related to

Pageof 19
Sort By:
International Journal of Antimicrobial Agents|November 25, 2000
Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjectsK de Gaetano Donati, S Bertagnolio, M Tumbarello, et al.
Le Infezioni in Medicina|May 22, 2003
[Bacterial pneumonia in HIV-infected patients]K. De Gaetano Donati, E. Tacconelli, M. Tumbarello, et al.
Gut|July 1, 1985
Peripheral blood mononuclear cells and regulatory T cells in acute viral hepatitisV Barnaba, E Tamburrini, V Laghi, et al.
Journal of Clinical & Laboratory Immunology|October 1, 1987
"Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)"M Levrero, V Barnaba, M Paroli, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|April 19, 2018
Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patientsEnrico Pola, F Taccari, G Autore, et al.
Viral Immunology|January 1, 1991
Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2S K Tyring, R Cauda, M Tumbarello, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1986
Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cellsA B Tilden, R Cauda, C E Grossi, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptidesR Cauda, M Tumbarello, L Ortona, et al.
European Journal of Haematology|September 10, 1999
Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathyR Cauda, M B Lucia, G Marasca, et al.
Pathologica|November 1, 1989
[Visceral leishmaniasis in patients with AIDS. Description of 2 cases]G Federico, R Cauda, E Pizzigallo, et al.
Pageof 19

Showing results (111-120 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Antimicrobial Agents|November 25, 2000
Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjectsK de Gaetano Donati, S Bertagnolio, M Tumbarello, et al.
Le Infezioni in Medicina|May 22, 2003
[Bacterial pneumonia in HIV-infected patients]K. De Gaetano Donati, E. Tacconelli, M. Tumbarello, et al.
Gut|July 1, 1985
Peripheral blood mononuclear cells and regulatory T cells in acute viral hepatitisV Barnaba, E Tamburrini, V Laghi, et al.
Journal of Clinical & Laboratory Immunology|October 1, 1987
"Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)"M Levrero, V Barnaba, M Paroli, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|April 19, 2018
Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patientsEnrico Pola, F Taccari, G Autore, et al.
Viral Immunology|January 1, 1991
Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2S K Tyring, R Cauda, M Tumbarello, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1986
Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cellsA B Tilden, R Cauda, C E Grossi, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptidesR Cauda, M Tumbarello, L Ortona, et al.
European Journal of Haematology|September 10, 1999
Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathyR Cauda, M B Lucia, G Marasca, et al.
Pathologica|November 1, 1989
[Visceral leishmaniasis in patients with AIDS. Description of 2 cases]G Federico, R Cauda, E Pizzigallo, et al.
Pageof 19